agilon health Management

Management criteria checks 2/4

agilon health's CEO is Steve Sell, appointed in Jun 2020, has a tenure of 3.83 years. total yearly compensation is $8.04M, comprised of 9.3% salary and 90.7% bonuses, including company stock and options. directly owns 0.017% of the company’s shares, worth $359.94K. The average tenure of the management team and the board of directors is 3.3 years and 3.8 years respectively.

Key information

Steve Sell

Chief executive officer

US$8.0m

Total compensation

CEO salary percentage9.3%
CEO tenure3.8yrs
CEO ownership0.02%
Management average tenure3.3yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

agilon health: Still Not Healthy Enough To Warrant Upside

Apr 19

Is agilon health (NYSE:AGL) Using Too Much Debt?

Apr 04
Is agilon health (NYSE:AGL) Using Too Much Debt?

agilon health: High Growth But Unsustainable Economics

Nov 20

agilon health: Strong Sales Growth, Lacks Remaining Value Drivers

Sep 13

Market Participants Recognise agilon health, inc.'s (NYSE:AGL) Revenues

Jul 17
Market Participants Recognise agilon health, inc.'s (NYSE:AGL) Revenues

agilon health: A Hold Until Margins Are Improved

Jun 30

An Intrinsic Calculation For agilon health, inc. (NYSE:AGL) Suggests It's 35% Undervalued

Jun 06
An Intrinsic Calculation For agilon health, inc. (NYSE:AGL) Suggests It's 35% Undervalued

Is It Time To Consider Buying agilon health, inc. (NYSE:AGL)?

Apr 28
Is It Time To Consider Buying agilon health, inc. (NYSE:AGL)?

agilon gains after boosting Medicare membership outlook

Jan 09

Is There An Opportunity With agilon health, inc.'s (NYSE:AGL) 39% Undervaluation?

Dec 19
Is There An Opportunity With agilon health, inc.'s (NYSE:AGL) 39% Undervaluation?

agilon health: Back To Long-Term Range, Despite Underlying Market Growth

Dec 15

CEO Compensation Analysis

How has Steve Sell's remuneration changed compared to agilon health's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-US$195m

Sep 30 2023n/an/a

-US$89m

Jun 30 2023n/an/a

-US$88m

Mar 31 2023n/an/a

-US$92m

Dec 31 2022US$8mUS$750k

-US$92m

Sep 30 2022n/an/a

-US$108m

Jun 30 2022n/an/a

-US$114m

Mar 31 2022n/an/a

-US$391m

Dec 31 2021US$1mUS$750k

-US$384m

Sep 30 2021n/an/a

-US$387m

Jun 30 2021n/an/a

-US$363m

Mar 31 2021n/an/a

-US$69m

Dec 31 2020US$6mUS$433k

-US$63m

Compensation vs Market: Steve's total compensation ($USD8.04M) is above average for companies of similar size in the US market ($USD5.57M).

Compensation vs Earnings: Steve's compensation has increased whilst the company is unprofitable.


CEO

Steve Sell (57 yo)

3.8yrs

Tenure

US$8,039,173

Compensation

Mr. Steven Jackson Sell, also known as Steve, has been President and Chief Executive Officer at Agilon Health, Inc. since June 1, 2020 and also has been its Director since June 2020. Mr. Sell also serves a...


Leadership Team

NamePositionTenureCompensationOwnership
Steven Sell
President3.8yrsUS$8.04m0.017%
$ 359.9k
Timothy Bensley
Chief Financial Officer3.3yrsUS$2.71m0.0050%
$ 106.5k
Girish Venkatachaliah
Chief Technology Officer3.3yrsUS$2.16m0.0033%
$ 70.4k
Benjamin Shaker
Chief Markets Officer3.6yrsUS$2.59m0.055%
$ 1.2m
Veeral Desai
Chief Strategy & Development Officer7yrsUS$2.92m0.066%
$ 1.4m
Timothy Gertsch
VP, Controller & Chief Accounting Officer2yrsno data0.014%
$ 301.2k
Matthew Gillmor
Vice President of Investor Relationsno datano datano data
Denise Zamore
Chief Legal Officer & Secretary1.7yrsno datano data
Claire Mulhearn
Chief Communications & Public Affairs Officer2.7yrsno datano data
Mat Varghese
Chief People Officer2.5yrsno datano data
Bill Farry
Chief of Technology Innovationno datano datano data
Kenny Bellendir
Markets Chief Financial Officerno datano datano data

3.3yrs

Average Tenure

45.5yo

Average Age

Experienced Management: AGL's management team is considered experienced (3.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Steven Sell
President3.8yrsUS$8.04m0.017%
$ 359.9k
Ronald Williams
Chairman of the Board7.3yrsUS$160.06k0.87%
$ 18.4m
Ravi Sachdev
Vice Chairman of the Board7.3yrsno datano data
Sharad Mansukani
Independent Director7.3yrsUS$245.06k0.30%
$ 6.4m
Jeffrey Schwaneke
Independent Director1.7yrsUS$135.67k0.0064%
$ 135.7k
Silvana Battaglia
Independent Directorless than a yearno datano data
Diana McKenzie
Independent Director1.2yrsno datano data
Karen McLoughlin
Independent Director2.8yrsUS$230.06k0.0019%
$ 40.3k
John Wulf
Independent Director7.3yrsUS$230.06k0.030%
$ 636.7k

3.8yrs

Average Tenure

57yo

Average Age

Experienced Board: AGL's board of directors are considered experienced (3.8 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.